Identifying surgical planes in minimally invasive lung surgery using fluorography
Tubeless Intersegmentectomy Plane Identification With Inflation- Deflation Line Combined With Fluorography
This study is testing a new method using special imaging to help surgeons find the right areas to operate on during lung surgery for patients with certain lung issues, aiming to make the surgery quicker and safer.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 18 Years to 85 Years |
| Sex | All |
| Sponsor | The Second Hospital of Shandong University Academic / other |
| Locations | 1 site (Jinan, Other (Non U.s.)) |
| Trial ID | NCT05479825 on ClinicalTrials.gov |
What this trial studies
This study evaluates a novel approach combining the inflation-deflation method with ICG fluorography to enhance the identification of intersegmental planes during tubeless minimally invasive segmentectomy. It is a one-armed, prospective randomized controlled study focusing on patients undergoing surgery for benign pulmonary lesions or small pulmonary adenocarcinomas. The goal is to reduce operation time and postoperative complications by improving the clarity of the surgical plane. The study will assess consecutive patients to determine the effectiveness of this combined technique.
Who should consider this trial
Good fit: Ideal candidates include patients with benign pulmonary lesions or small pulmonary adenocarcinomas who can tolerate minimally invasive surgery.
Not a fit: Patients whose pulmonary function cannot tolerate minimally invasive surgery or for whom segmentectomy is not planned will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to shorter operation times and fewer complications for patients undergoing segmentectomy.
How similar studies have performed: While this approach is innovative, similar studies using fluorography in surgical settings have shown promise, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. cardio- pulmonary function can tolerate the minimally invasive surgery (including VATS and robotic surgery); 2. benign pulmonary lesion considering for segmentectomy; 3. ≤2cm pulmonary adenocarcinoma with ground- glass components, considering for segmentectomy. Exclusion Criteria: 1. cardio- pulmonary function can not tolerate the minimally invasive surgery (including VATS and robotic surgery); 2. segmentectomy is not considered as the surgery plan.
Where this trial is running
Jinan, Other (Non U.s.)
- Yunpeng Zhao — Jinan, Other (Non U.s.), China (Recruiting)
Study contacts
- Study coordinator: Yunpeng Zhao, doctor
- Email: zyp_baggio@163.com
- Phone: 18766188692
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.